Market closedRefreshes 15sData NSENot investment advice
Sicagen India

Sicagen India

NSE: SICAGENBSE 533014www.sicagen.com
TV Chart
53.17
1.83−3.33%
DAY51
₹53.17
57
52W51
₹53.17
62
Open54.25
Prev Close55.00
Bid53.15100
Ask53.20100
Volume27.7K+27%vs 20D avg
Market Cap₹212.78 Cr
Promoter Hold.61.13%
Face Value₹10
Fwd P/E
PEG
EV/EBITDA11.15
P/S0.17
ROA
Beta
Div Payout22.52%
Valuation

Sicagen India Ltd valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for Sicagen India Ltd, framed against the sector median so the premium or discount is obvious at a glance.

Sicagen India Ltd trades at a P/E of 9.36× and P/B of 0.34×, against the sector median P/E of 34.10×.

Key MetricsLive · as of 23 Jun 2026
the price tag

Valuation

Market Cap
₹212.78 Cr
P/E Ratio
good9.36
P/B Ratio
good0.34
EPS
4.44
the engine

Profitability

ROE
watch3.65%
ROCE
watch5.57%
Net Margin
watch1.86%
Op Margin
watch3.9%
the trajectory

Growth

EPS YoY
%
Revenue YoY
%
Qtr Sales
good25.9%
Qtr Profit
good100%
the balance sheet

Financial Health

Debt / Equity
good0.29
Book Value
131
Div Yield
avg1.8%
Promoter Hold.
good61.13%
Chart Patterns

Sicagen India Ltd chart patterns: breakouts, tops and bottoms.

Auto-detected classical chart patterns for Sicagen India Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.

Financials

Sicagen India Ltd financials: P&L, balance sheet, cash flow, ratios.

Twelve years of audited numbers for Sicagen India Ltd, switchable between annual and quarterly views, consolidated or standalone.

Sicagen India Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹212.78 Cr and reported EPS of ₹4.44.

Period201820192020202120222023202420252026
Revenue from Operations
740
820
699
542
836
895
795
892
973
Other Income
15
17
11
8
9
8
7
8
10
Total Income
755
837
710
550
845
903
803
900
983
Cost of Goods Sold (COGS)
652
731
620
477
761
810
711
790
861
Gross Profit
88
90
79
65
75
86
85
102
113
+Operating Expenses
87
88
67
56
53
59
58
67
74
EBITDA
1
1
11
8
22
27
27
36
39
+Non-Operating Expenses
14
15
19
15
8
26
20
24
23
Profit Before Tax (PBT)
2
3
3
1
5
22
14
24
25
+Tax Expense
1
3
3
5
6
4
3
7
7
Total Profit for Period
1
0
0
-3
-1
18
10
17
18
Net Profit (Owner's PAT)
1
0
0
-3
-1
18
10
17
18
Earnings Per Share (EPS)
0.29
0.03
0.09
-0.81
-0.15
4.50
2.65
4.32
4.57
Diluted Shares Outstanding (Nos.)
4
4
4
4
4
4
4
4
4
+Additional Disclosures
1,406
1,557
1,319
1,042
1,620
1,687
1,511
1,674
1,796
Sales Growth %
10.87
-14.81
-22.50
54.37
7.08
-11.15
12.12
9.15
YoY Sales Growth %
10.87
-14.81
-22.50
54.37
7.08
-11.15
12.12
9.15
Material Cost %
25
23
42
35
50
52
40
39
47
Employee Cost %
5
6
5
6
3
3
3
3
3
Other Cost %
6
5
5
5
3
4
4
4
4
OPM %
0
0
2
2
3
3
3
4
4
Tax %
30
95
89
322
112
18
24
29
28
Profit Growth %
-88.70
176.92
-988.89
80.94
3,021.31
-41.13
63.11
5.61
Gross Margin %
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA Margin %
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest Coverage Ratio
-0.00
-0.00
0.00
-0.00
0.00
0.00
0.00
0.00
0.00
+Additional Fields
-4
-5
1
-1
11
16
17
25
29
all values in ₹ Cr unless suffixed · source: company filings
Segment Analysis

Sicagen India segment analysis: revenue and profit mix.

Disclosed business segments at Sicagen India with their share of revenue and profit, switchable between consolidated and standalone reporting.

Sicagen India discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Investment Thesis

Sicagen India Ltd investment thesis: bull case, bear case, and the flip lines.

Why someone would buy Sicagen India Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.

bull case

What you're getting.

No strengths or opportunities on record.

bear case

What can break it.

No weaknesses or threats on record.

flip conditions

What would change my mind.

  • Trim if P/E re-rates above 12 (~0.4× the sector multiple of 34.1). The valuation cushion thins from there.

  • Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.

  • Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.

  • Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.

Shareholding

Sicagen shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in Sicagen — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

Loading shareholding data...

Peers

Sicagen India Ltd peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Sicagen India Ltd is highlighted for quick read-across.

Quick Compare

Largest by Market Cap
International Gemmological Institute (India) Limited
₹15,367.6 Cr
Best Profit Growth
Indiabulls Limited
737.00 %
Highest Dividend Yield
Majestic Auto Ltd
11.74 %
Technicals

Sicagen India Ltd technical analysis: indicators, pivots and CPR.

Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Sicagen India Ltd — derived from the live tape, not yesterday's close.

Sicagen India Ltd last traded at ₹53.17 with an intraday range of ₹50.56–₹57 — live indicator, pivot and CPR signals below.

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Live: ₹53.17
LevelPrice (₹)Distance% Δ
R469.47+16.30+30.66%
R363.03+9.86+18.55%
R260.02+6.85+12.88%
R156.59+3.42+6.44%
PIVOT53.580.410.76%
CURRENT53.17
S137.27-15.90-29.90%
S243.71-9.46-17.79%
S347.14-6.03-11.35%
S450.15-3.02-5.67%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 53.37P: 53.58TC: 53.78
R1
R2
R3
R4
indicator
LTP: 53.17
PDH: 55.49
PDL: 54.50
● Market Sentiment

SICAGEN is trading Below CPR, indicating Bearishness

● CPR Width

CPR is Wider, suggesting unlikely for trending moves

● Opening Range

Day's range: 54.25 ~ 55.9

● Price Position

Trading Below opening range, showing Bearishness

Delivery & Volume

Sicagen India Ltd delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for Sicagen India Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in Sicagen India Ltd stood at 65.4% of traded volume, against a 20-day average of 68.0%.

Avg Delivery (20D)68%-2.5 ppt latest vs avg
Highest Delivery84%on 22 Jun
Avg Volume (20D)21.8 K20-day run-rate
Conviction Trend↑ Strengthening-2.5 ppt latest read
Volume & Delivery · last 20 sessions
Filings & Concalls

Sicagen India announcements: results, concalls, ratings, M&A.

Filings Sicagen India sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

No filings or concall transcripts on record.

Corporate Actions

Sicagen India dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue Sicagen India has declared, sequenced by announce and record date.

Sicagen India corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

About the Company

About Sicagen India Ltd: business, sector, key facts.

What Sicagen India Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

Sicagen India Ltd is a listed Indian equity, listed as NSE: SICAGEN, BSE: 533014.

SICAGEN
Listed Equity

Sicagen India Ltd

NSE · SICAGEN·BSE · 533014·www.sicagen.com
company facts
Employees
Sector
Headquarters
Market Cap₹212.78 Cr
Listed OnNSE · BSE
leadership10 on record
D. Aditya Kiran
Regional Sales Manager of Building Materials
D. Sivakumar
Chief Manager of IPD
G. Karthikeyan
Head (PCS)
Kotasthane Kedar Dinesh
Manager
K. Ramesh
Branch Sales Manager
Mr. Prasanna Joshi
Vice President
Ms. Ankita Jain
Company Secretary & Compliance Officer
Ms. K. Lalitha
Chief Financial Officer
R. M. Muthuraman
Chief Manager
V. R. Krishnan
Dy. General Manager of HR
§ ∞ · Plainly Answered

Questions investors ask about Sicagen India Ltd (SICAGEN).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of Sicagen India Ltd (SICAGEN)?

The current share price of Sicagen India Ltd (SICAGEN) is ₹53.17. Today, the stock has declined by ₹1.83 (3.33%), trading in a range of ₹50.56 to ₹57. The stock opened at ₹54.25 with a trading volume of 27,657 shares.

02Is Sicagen India Ltd stock a good investment for long-term?

Sicagen India Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹212.78 crores, P/E ratio of 9.36, ROE of 3.65%, and ROCE of 5.57%. The dividend yield stands at 1.80%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of Sicagen India Ltd stock?

The 52-week high price of Sicagen India Ltd (SICAGEN) is ₹61.5, while the 52-week low is ₹51.1. Currently trading at ₹53.17, the stock is 19.9% away from its 52-week low and 13.5% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy Sicagen India Ltd stock at the current price?

Whether to buy Sicagen India Ltd stock at ₹53.17 depends on multiple factors. The stock is currently trading with a P/E ratio of 9.36 and P/B ratio of 0.34. Today's performance shows a loss of 3.33%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of Sicagen India Ltd and when is the next dividend?

Sicagen India Ltd offers a dividend yield of 1.80%, which means for every ₹100 invested at the current price of ₹53.17, you can expect to receive approximately ₹1.80 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of Sicagen India Ltd?

Sicagen India Ltd's key financial metrics include: P/E Ratio: 9.36, P/B Ratio: 0.34, ROE: 3.65%, ROCE: 5.57%, Dividend Yield: 1.80%, EPS: ₹4.44, Book Value: ₹131, and Debt-to-Equity: 0.29. The company's market cap stands at ₹212.78 crores. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is Sicagen India Ltd stock performing today in the market?

Sicagen India Ltd stock opened at ₹54.25 and is currently trading at ₹53.17, showing a decline of ₹1.83 (3.33%). The intraday high is ₹57 and low is ₹50.56. The trading volume stands at 27,657 shares, indicating moderate market participation today.

08What is the P/E ratio of Sicagen India Ltd and what does it indicate?

Sicagen India Ltd has a Price-to-Earnings (P/E) ratio of 9.36, which means investors are willing to pay ₹9.36 for every ₹1 of earnings. With an EPS of ₹4.44, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about Sicagen India Ltd (SICAGEN) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.